Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 256 AL 270

Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential

Abushakra S, Porsteinsson A, Scheltens P, Sadowsky C, Vellas B, Cummings J, Gauthier S, Hey JA, Power A, Wang P, Shen L, Tolar M.

J Prev Alzheimers Dis. 2017;4(3):149-156. doi: 10.14283/jpad.2017.26.

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, Santarelli L, Fontoura P; SCarlet RoAD Investigators.

Alzheimers Res Ther. 2017 Dec 8;9(1):95. doi: 10.1186/s13195-017-0318-y.

Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment

Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A.

Sci Rep. 2017 Dec 13;7(1):17490. doi: 10.1038/s41598-017-17718-y.

[Music therapy as a non-pharmacological treatment in Alzheimer's disease. A systematic review]

Garcia-Casares N, Moreno-Leiva RM, Garcia-Arnes JA.

Rev Neurol. 2017 Dec 16;65(12):529-538.

Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial

Jia Y, Zhang X, Yu J, Han J, Yu T, Shi J, Zhao L, Nie K.

BMC Complement Altern Med. 2017 Dec 29;17(1):556. doi: 10.1186/s12906-017-2064-x.

The clinical efficacy of reminiscence therapy in patients with mild-to-moderate Alzheimer disease: Study protocol for a randomized parallel-design controlled trial

Li M, Lyu JH, Zhang Y, Gao ML, Li WJ, Ma X.

Medicine (Baltimore). 2017 Dec;96(51):e9381. doi: 10.1097/MD.0000000000009381.

Remembering Reminiscence

Kris AE, Henkel LA.

J Gerontol Nurs. 2017 Jun 1;43(6):3-4. doi: 10.3928/00989134-20170512-01.

Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and Dementia

Knöchel C, Voss M, Gruter F, Alves GS, Matura S, Sepanski B, Stablein M, Kraft D, Prvulovic D, Carvalho AF, Reif A, Oertel-Knochel V.

Curr Alzheimer Res. 2017;14(3):240-254. doi: 10.2174/1567205013666160602235520.

Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series

Devanand DP, Pelton GH, D'Antonio K, Strickler JG, Kreisl WC, Noble J, Marder K, Skomorowsky A, Huey ED.

Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):73-75. doi: 10.1097/WAD.0000000000000161.

Alzheimer's Disease and Exercise: A Literature Review

Cass SP.

Curr Sports Med Rep. 2017 Jan/Feb;16(1):19-22. doi: 10.1249/JSR.0000000000000332.

Nonpharmacological Strategies for Patients With Early-Stage Dementia or Mild Cognitive Impairment: A 10-Year Update

Anderson JG, Lopez RP, Rose KM, Specht JK.

Res Gerontol Nurs. 2017 Jan 1;10(1):5-11. doi: 10.3928/19404921-20161209-05.

Vitamin E for Alzheimer's dementia and mild cognitive impairment

Farina N, Llewellyn D, Isaac MG, Tabet N.

Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD002854. doi: 10.1002/14651858.CD002854.pub4.

Social network and cognitive functioning in old age : Self-efficacy as a mediator?

Fankhauser S, Maercker A, Forstmeier S.

Z Gerontol Geriatr. 2017 Feb;50(2):123-131. doi: 10.1007/s00391-016-1178-y. Epub 2017 Jan 27.

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease

Geifman N, Brinton RD, Kennedy RE, Schneider LS, Butte AJ.

Alzheimers Res Ther. 2017 Feb 17;9(1):10. doi: 10.1186/s13195-017-0237-y.

Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease

Jia J, Gauthier S, Pallotta S, Ji Y, Wei W, Xiao S, Peng D, Guo Q, Wu L, Chen S, Kuang W, Zhang J, Wei C, Tang Y.

Alzheimers Dement. 2017 May;13(5):592-597. doi: 10.1016/j.jalz.2017.01.007. Epub 2017 Feb 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias